Company Management

Amolyt Pharma

Biotechnology Research Ecully, Rhône, Fr 32 employees

Employees: 32
Contacts: 2
Emails: 2
Phones: 1

amolytpharma.com LinkedIn Crunchbase

Amolyt Pharma Overview

Headquarters: Ecully, Rhône, Fr
Phone Number: Available in AeroLeads
Website: amolytpharma.com
Industry: Biotechnology Research
Employees: 32
Founded: 2015
Funding: 138.6M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Hypoparathyroidism Endocrinology Metabolic Disease Therapeutic Peptides Endocrine Disease Rare Disease

About Amolyt Pharma

Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for hypoparathyroidism, and AZP-3813, a peptide growth hormone receptor antagonist for the potential treatment of acromegaly. Amolyt Pharma aims to further expand and develop its portfolio by leveraging its global network in the field of endocrinology and with support from a strong syndicate of international investors.

Amolyt Pharma Contact Details

People in AeroLeads: 4
With contact data: 2
Email contacts: 2; 50.0% coverage
Phone contacts: 1; 25.0% coverage

Amolyt Pharma Org Chart

Sample employees and titles

Name	Title	Location	Contact
Delphine Martinez	General Counsel, Executive Officer		View
Olivier Favre-Bulle	Founder and CEO of 3biotech - Cmc		View
Michael Culler	Cso for Amolyt Pharma. Scientific	Greater Boston, United States	Email Phone
Gaëlle Charier, Phd, PMP®	Associate Director, Clinical Project	Le Cannet, Provence-alpes-côte D'azur, France	Email